BACKGROUND: Linkage and knock-out mice studies suggest that the melanocortin-3-receptor (MC3R) is a candidate gene for obesity. OBJECTIVE: To evaluate whether MC3R mutations underlie morbid obesity. SUBJECTS AND METHODS: MC3R coding and 5 0 -flanking regions were sequenced in 48 subjects and the detected variants genotyped in 252 morbidly obese (BMI ! 40 kg/m 2 ) Finns. Gel shifts were used to examine whether a mutation in the putative promoter alters GATA-factor binding. RESULTS: Three common MC3R variants were found: a 17C > A variant, changing Thr6?Lys in 16%, a 241G > A variant changing Val81?Ile in 15%, and a 7239A > G substitution in the GATA binding site in 21% of the subjects. Four other variants were detected in the 5 0 flanking region. Frequencies of the three common variants did not differ between obese and contol subjects. Among the obese, the 17C > A and 241G > A variants were coinherited and associated with increased insulin -glucose ratios (P < 0.05) and leptin levels (P < 0.05). GATA-4 bound efficiently to wild type oligonucleotide, but only weakly to the oligonucleotide with the 7239A > G mutation. CONCLUSIONS: MC3R gene variants are common and do not explain human morbid obesity. These variants associated with subtle changes in onset of weight gain, hyperleptinemia and insulin -glucose ratios. The 7239A > G mutation abolishes binding of GATA-4 to the MC3R promoter region.
Introduction
The proportion of body fat is reflected by circulating leptin and insulin levels, and long-term homeostasis of body weight is accomplished by integration of these hormonal signals by hypothalamic centers. 1 -3 Neuropeptides derived from the ACTH precursor pro-opiomelanocortin (POMC) and melanocortin receptors (MCRs) play a key role in this complex control of appetite and body weight.
1,2 MC3R and MC4R are both highly expressed in brain areas involved in regulation of energy balance. 2 The MC4R plays an important role in energy homeostasis, as its targeted disruption causes hyperphagia and obesity in mice. 4 MC4R mutations underlie up to 4% of severe early-onset or adult obesity. 5, 6 Observed linkage between obesity and the chromosomal region 20q13 also makes the MC3R gene a plausible candidate gene for human obesity. 7 Furthermore, disruption of MC3R in mice results in increased fat mass, hyperleptinemia and insulin resistance. 8, 9 We examined whether mutations in the MC3R gene underlie morbid obesity and/or are associated with changes in metabolic parameters.
Subjects and methods
A cohort of 252 morbidly obese (BMI ! 40 kg/m 2 , 182 females/70 males, age 21 -67 y, prevalence of diabetes and hypertension 24 and 45%, respectively) patients was collected between 1989 -1995. 10 History of weight development was assessed by questionnaire. For mutation detection, 1400 bp of the 5 0 -flanking region and the whole coding region of the MC3R gene were sequenced in 48 subjects and the variants detected genotyped in the rest of the cohort. Blood samples from 312 healthy blood donors (153 females and 159 males) from the Finnish Red Cross Blood Transfusion Service served as controls for estimation of allele frequencies in the background population. Leptin concentrations were determined by radioimmunoassay (Linco Research Inc., St Charles, MO, USA) with intra-and interassay CV's of less than 5%. Glucose, insulin and lipid levels were measured as previously described. 10 DNA sequencing and genotyping After PCR, the MC3R gene was sequenced using primers pairs: ]ATP before annealing. Binding reactions were carried out as described. 13 The antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
Statistical analyses
Mann -Whitney rank-sum test was used to analyse differences between group means and Fisher's exact test for frequency distributions.
Results

MC3R gene variants
Two common missense mutations were found in the MC3R coding region: nucleotide 17C > A changing amino acid 6 from threonine to lysine and 241G > A changing amino acid 81 from valine to isoleucine. Five additional variants, 7939G > C, 7911G > A, 7803T > C, 7373G > T and 7239A > G were detected in the putative promoter region. The 7239A > G variant was localized in a consensus GATA transcription factor binding site 13 (aaacaaGATAaaaact), comprising nucleotides 7244 to 7228 of the MC3R gene (common allelic form in bold and underlined).
The genotype frequencies for the 17C > A, 241G > A and 7239A > G variants did not differ between morbidly obese and the control population (Table 1A) .
The 7239A > G variant and GATA binding In EMSAs, nuclear extracts abundantly containing GATA-4/ GATA-6 yielded a strong retarded band A with the wild type probe (Figure 1, lane 1) , whereas assays using the MC3Rmut oligonucleotide revealed only a weak protein -DNA complex ( Figure 1, lanes 9 and 10) . In an excess of unlabelled 
MC3R variants and metabolic parameters
The 17C > A and 241G > A gene variants were coinherited in all but 3 cases, indicating an almost complete linkage disequilibrium. Individuals with the combined genotype of 17CC/241GG had lower insulin -glucose ratios and lower leptin levels and tended to weigh less at 20 y than those with the combined variant genotypes (Table 1B) . A carrier status for the 7239A > G variant was associated with a tendency towards lower maximal BMI values when compared to wild type homozygotes (45.7 AE 0.7 vs 47.7 AE 0.5 kg/m 2 ; P ¼ 0.06).
Discussion
The GATA-binding proteins are zinc finger transcription factors regulating gene expression, differentiation and cell proliferation. 14 We demonstrate that of the different GATA proteins 3, 4 and 6, GATA-4 was responsible for binding to the MC3R promoter GATA site. GATA-4 is expressed in pituitary and hypothalamic cells, gonadal and adrenal cells 15, 16 and MC3R in the brain cortex, thalamus, hippocampus, pituitary and hypothalamus. 17 -19 The expression patterns for these two genes thus overlap, suggesting that GATA-4 is a regulator of the MC3R in vivo. The 7239A > G variant was associated with a tendency towards lower maximal BMI (45.7 AE 0.7 vs 47.7 AE 0.5 kg/m 2 ; P ¼ 0.06) and was also an independent predictor of maximal BMI in the obese (stepwise forward regression analysis; R-squared increment ¼ 0.019; P ¼ 0.03), indicating that it may exert a modulating effect on development of maximal weight.
Three detected MC3R gene variants were common in the obese as well as in control subjects and therefore do not explain morbid obesity. The Thr6?Lys mutation is located in the extracellular N-terminus and the Val81?Ile in the first transmembrane part of MC3R. Within the morbidly obese, the rare amino acid variants were associated with higher leptin levels and insulin -glucose ratios compared to subjects homozygous for the common variants. They also reported a tendency towards higher BMI at 20 y. Hani et al found increased insulin -glucose ratios in healthy subjects with the variant MC3R alleles compared to healthy subjects with the wild type alleles. 20 Collectively, these data indicate that the MC3R gene variants may induce subtle changes in obesity-related parameters and that these changes are not restricted to morbidly obese subjects.
